Srishti Gupta
Direttore/Membro del Consiglio presso IDORSIA LTD
Patrimonio netto: 37 108 $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jean-Paul Clozel | M | 69 |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 7 anni |
| Mathieu Simon | M | 68 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 5 anni |
| Marc Elia | M | 48 | 2 anni | |
| André Muller | M | 60 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 7 anni |
| Christine Regan Lindenboom | F | 43 | 2 anni | |
| Julien Gander | M | 45 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | - |
| Jill Andersen | F | 51 | 3 anni | |
| Jörn Aldag | M | 65 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 4 anni |
| Terry McGuire | M | 68 | 4 anni | |
| Sandy Mahatme | M | 59 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 4 anni |
| Peter Kellogg | M | 67 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 3 anni |
| Felix R. Ehrat | M | 67 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 4 anni |
| Sara Cotter | F | 43 | 1 anni | |
| Andrew C. Weiss | M | 55 | 7 anni | |
| William Duke | M | 51 | 1 anni | |
| Julie Green | F | 49 | - | |
| Tamsin Berry | F | 43 | 2 anni | |
| Robert Allen | M | 55 | 1 anni | |
| Alberto Gimona | M | 64 | 5 anni | |
| Sophie Kornowski-Bonnet | M | 61 | 1 anni | |
| Stacy Price | F | 55 | 1 anni | |
| Simon Jose | M | 58 | 6 anni | |
| Alexander Khatuntsev | M | 45 | 7 anni | |
| Jeremy Gowler | M | 47 | 2 anni | |
| Martine Clozel | M | 68 | 7 anni | |
| Heidi Spurling | F | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Michael Wyzga | M | 69 | 3 anni | |
| Tomas Jan Heyman | M | 68 | 3 anni | |
| Clive Meanwell | M | 67 | 2 anni | |
| Guy Braunstein | M | 67 | 7 anni | |
| Cristina A. Wilbur | F | 57 |
International School of the Basel Region AG
 International School of the Basel Region AG Other Consumer ServicesConsumer Services International School of the Basel Region AG provides primary and secondary school services. The private company is based in Reinach, Switzerland. | 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Svizzera | 16 | 51.61% |
| Stati Uniti | 15 | 48.39% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Srishti Gupta
- Contatti personali
